本页面由Tiger Trade Technology Pte. Ltd.提供服务

ReShape Lifesciences, Inc.

15.68
0.0000
成交量:- -
成交额:5,379.51万
市值:3,741.19万
市盈率:-0.16
高:15.68
开:15.68
低:15.68
收:15.68
52周最高:15.68
52周最低:15.68
股本:238.60万
流通股本:238.44万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-96.2212
净资产收益率:--
总资产收益率:--
市净率:--
市盈率(LYR):- -

数据加载中...

2025/05/14

SEC问询函

Form CORRESP - Correspondence
2025/05/09

重要事件披露

Form 8-K - Current report
2025/04/29

重要事件披露

Form 8-K - Current report
2025/04/21

重要事件披露

Form 8-K - Current report
2025/04/21

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/04/04

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/04/02

重要事件披露

Form 8-K - Current report
2025/03/20

重要事件披露

Form 8-K - Current report
2025/02/21

重要事件披露

Form 8-K - Current report
2025/02/15

SEC问询函

Form CORRESP - Correspondence
2025/02/14

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/02/14

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/02/14

SEC问询函

Form CORRESP - Correspondence
2025/02/13

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/02/13

SEC问询函

Form CORRESP - Correspondence
2025/02/07

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/02/06

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/01/21

重要事件披露

Form 8-K - Current report
2025/01/21

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2025/01/15

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]